TITAN PHARMACEUTICALS INC — Director's Dealing 2011

Apr 19, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2011-04-15

Reporting Person: BHONSLE SUNIL (Director, President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-15	Option to Purchase Common Stock	$1.40	A	200000	Acquired	2021-04-15	Common Stock (200000)	Direct

Footnotes

F1: These options vest 25% on October 15, 2011 and the balance in 18 equal monthly installments thereafter.